Cong Ning Guanmo Liu Junwei Zhang Xiaobo Yang Yiyao Xu Haitao Zhao
10.3389/fimmu.2023.1159885
Front Immunol
2023 May 9;14:1159885.
associating liver partition and portal vein ligation for staged hepatectomy future liver remnant immune checkpoint inhibitors immunotherapy unresectable hepatocellular carcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/37228608/
Carcinoma, Hepatocellular / etiology Carcinoma, Hepatocellular / surgery Liver Neoplasms / etiology Liver Neoplasms / surgery
Carcinoma, Hepatocellular / etiology Carcinoma, Hepatocellular / surgery Liver Neoplasms / etiology Liver Neoplasms / surgery Case Reports Hepatectomy / adverse effects Hepatitis B virus Humans Immune Checkpoint Inhibitors / therapeutic use Portal Vein / pathology Portal Vein / surgery Immune Checkpoint Inhibitors
PMC10203512
37228608
Case Report: The application of associating liver partition and portal vein ligation for staged hepatectomy in patients with hepatitis b virus-related hepatocellular carcinoma after undergoing treatment with an immune checkpoint inhibitor: a report of two cases
2023